🇺🇸 FDA
Patent

US 11365180

Resolution method for axis chiral enantiomers of lesinurad

granted A61KA61K31/4196A61P

Quick answer

US patent 11365180 (Resolution method for axis chiral enantiomers of lesinurad) held by CHINA RESOURCES SAIKE PHARMACEUTICAL CO., LTD. expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CHINA RESOURCES SAIKE PHARMACEUTICAL CO., LTD.
Grant date
Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/4196, A61P, A61P19/06